Ryan Specialty (RYAN) Competitors

$53.71
+0.38 (+0.71%)
(As of 05/10/2024 ET)

RYAN vs. EQH, ERIE, BRO, WTW, AJG, DOC, BAP, RGA, AMH, and BIP

Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Equitable (EQH), Erie Indemnity (ERIE), Brown & Brown (BRO), Willis Towers Watson Public (WTW), Arthur J. Gallagher & Co. (AJG), Healthpeak Properties (DOC), Credicorp (BAP), Reinsurance Group of America (RGA), American Homes 4 Rent (AMH), and Brookfield Infrastructure Partners (BIP). These companies are all part of the "finance" sector.

Ryan Specialty vs.

Ryan Specialty (NYSE:RYAN) and Equitable (NYSE:EQH) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation.

Ryan Specialty has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Equitable has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500.

Ryan Specialty pays an annual dividend of $0.44 per share and has a dividend yield of 0.8%. Equitable pays an annual dividend of $0.88 per share and has a dividend yield of 2.2%. Ryan Specialty pays out 83.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Equitable pays out 27.2% of its earnings in the form of a dividend. Equitable is clearly the better dividend stock, given its higher yield and lower payout ratio.

Ryan Specialty has a net margin of 9.15% compared to Equitable's net margin of 0.00%. Ryan Specialty's return on equity of 45.87% beat Equitable's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty9.15% 45.87% 6.28%
Equitable N/A N/A N/A

Equitable received 234 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 60.47% of users gave Equitable an outperform vote while only 37.70% of users gave Ryan Specialty an outperform vote.

CompanyUnderperformOutperform
Ryan SpecialtyOutperform Votes
23
37.70%
Underperform Votes
38
62.30%
EquitableOutperform Votes
257
60.47%
Underperform Votes
168
39.53%

Ryan Specialty currently has a consensus price target of $54.25, indicating a potential upside of 1.01%. Equitable has a consensus price target of $40.10, indicating a potential upside of 0.65%. Given Ryan Specialty's higher possible upside, research analysts plainly believe Ryan Specialty is more favorable than Equitable.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.22
Equitable
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

Equitable has higher revenue and earnings than Ryan Specialty. Equitable is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$2.08B6.73$61.04M$0.53101.34
Equitable$10.53B1.23$1.05B$3.2312.33

In the previous week, Ryan Specialty had 2 more articles in the media than Equitable. MarketBeat recorded 12 mentions for Ryan Specialty and 10 mentions for Equitable. Equitable's average media sentiment score of 0.87 beat Ryan Specialty's score of 0.45 indicating that Equitable is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Equitable
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 92.7% of Equitable shares are held by institutional investors. 11.1% of Ryan Specialty shares are held by insiders. Comparatively, 1.1% of Equitable shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Equitable beats Ryan Specialty on 12 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyInsurance agents, brokers, & service IndustryFinance SectorNYSE Exchange
Market Cap$13.98B$17.72B$9.72B$17.89B
Dividend Yield0.82%2.51%6.30%3.47%
P/E Ratio101.3425.2737.1221.78
Price / Sales6.7328.853,465.0110.04
Price / Cash21.4726.1628.1617.93
Price / Book14.327.943.096.05
Net Income$61.04M$953.69M$1.01B$966.66M
7 Day Performance4.29%2.47%1.06%1.48%
1 Month Performance7.57%4.96%2.59%2.59%
1 Year Performance23.08%7.67%19.68%131.38%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EQH
Equitable
4.4004 of 5 stars
$39.43
+0.7%
$40.30
+2.2%
+70.0%$12.82B$10.53B12.218,500Analyst Forecast
Short Interest ↓
ERIE
Erie Indemnity
3.6751 of 5 stars
$405.44
+1.2%
N/A+73.8%$21.20B$3.27B43.786,556Short Interest ↓
Positive News
BRO
Brown & Brown
4.7929 of 5 stars
$85.26
+1.2%
$87.30
+2.4%
+32.6%$24.32B$4.26B26.239,705Analyst Downgrade
Short Interest ↓
WTW
Willis Towers Watson Public
4.1677 of 5 stars
$254.86
+0.7%
$295.54
+16.0%
+12.5%$26.06B$9.58B25.5648,000Short Interest ↑
Analyst Revision
AJG
Arthur J. Gallagher & Co.
4.8129 of 5 stars
$245.02
+0.8%
$255.31
+4.2%
+15.7%$53.54B$10.07B49.6052,000Short Interest ↓
Positive News
DOC
Healthpeak Properties
4.1068 of 5 stars
$19.21
+1.3%
$18.50
-3.7%
+35.9%$13.52B$2.18B54.89193Short Interest ↑
BAP
Credicorp
3.8749 of 5 stars
$169.73
0.0%
$181.73
+7.1%
+24.1%$13.50B$6.54B10.8537,074Dividend Increase
News Coverage
Gap Up
RGA
Reinsurance Group of America
4.6882 of 5 stars
$203.32
+1.2%
$194.85
-4.2%
+39.7%$13.38B$18.57B15.803,900Earnings Report
Analyst Forecast
News Coverage
High Trading Volume
AMH
American Homes 4 Rent
4.0668 of 5 stars
$36.48
+1.1%
$39.67
+8.7%
+3.1%$13.36B$1.62B37.221,725Earnings Report
Dividend Announcement
Insider Buying
News Coverage
Positive News
BIP
Brookfield Infrastructure Partners
4.4723 of 5 stars
$29.96
-0.8%
$38.20
+27.5%
-12.6%$13.82B$17.93B96.6552,000Short Interest ↑

Related Companies and Tools

This page (NYSE:RYAN) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners